查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1792259

神经刺激设备市场报告（按刺激类型、设备类型、应用、最终用户和地区）2025 年至 2033 年

Neurostimulation Devices Market Report by Stimulation Type, Device Type, Application, End-User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球神经刺激设备市场规模达96亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到220亿美元，2025-2033年期间的复合年增长率（CAGR）为9.21%。人口老化加剧、医疗支出不断增长、非侵入性或微创神经刺激技术的发展，以及政府和私人医疗保险公司报销政策的改进，是推动市场发展的主要因素。

神经刺激装置是一种先进的医疗技术，旨在调节和影响人体内的神经活动。这些装置透过向神经系统的特定区域传递电脉衝或磁脉衝来发挥作用，旨在缓解各种神经系统疾病和慢性疾病。它们提供了一种前景光明的非侵入性或微创治疗方法，能够提高患者的生活质量，并可能为治疗各种神经系统疾病开闢新的途径。神经刺激装置主要分为两种：深部脑部刺激 (DBS) 和脊髓刺激 (SBS)。 DBS 是指将电极植入目标脑区，以调节异常神经讯号，并治疗帕金森氏症、特发性震颤和肌张力失调等疾病。

日益增长的老龄化人口正在推动全球市场的发展。随着老龄人口的增长，用于治疗这些疾病的神经刺激设备的需求可能会上升。此外，非侵入性或微创神经刺激技术的发展扩大了潜在的患者群体，因为与传统外科手术相比，这些治疗方案通常风险更低、恢復时间更短。此外，一些地区的政府和私人医疗保险机构改进了报销政策，使患者更容易获得神经刺激治疗，从而促进了市场的成长。此外，正在进行的研究和临床试验也为神经刺激设备的安全性和有效性提供了更多证据。这些研究的积极成果增强了医务人员和患者对该技术的信心。此外，医疗保健支出的不断增长也支持了市场解决方案的成长，因为神经刺激设备提供了一种经济高效的慢性病管理方法，这推动了其应用。

神经刺激设备市场趋势/驱动因素：

神经系统疾病盛行率不断上升

帕金森氏症、癫痫、慢性疼痛和忧郁症等神经系统疾病困扰着全球数百万人，造成了沉重的医疗负担。神经刺激装置为那些对常规疗法无效或副作用严重的患者提供了一个相当有前景的解决方案。深部脑部刺激 (DBS) 在治疗帕金森氏症等运动障碍方面已显示出显着疗效，从而增加了对这些装置的需求。此外，慢性疼痛的发生率不断上升，尤其是由于人口老化和久坐不动的生活方式，这推动了对脊髓刺激 (SCS) 装置的需求，以便在不过度依赖药物的情况下缓解疼痛。随着政府和医疗机构将改善患者治疗效果放在首位并寻求创新解决方案，神经刺激装置的需求预计将稳定成长。

神经刺激技术的持续进步

持续的研发投入催生了更精密、更精准的神经刺激设备。创新包括更小巧、更精准的电极、更长的电池寿命，以及能够根据患者即时需求自动调整刺激参数的闭环系统整合。这些进步转化为更佳的治疗效果、更少的副作用和更高的患者舒适度。此外，神经刺激设备微创植入技术的发展，使其适用范围扩大到更广泛的患者群体，使治疗更容易获得，也更受患者和医护人员的青睐。随着技术的不断发展，神经刺激设备有望变得更有效率和适应性强，从而进一步推动其普及和市场渗透。

神经调节疗法的认知度和接受度不断提高

随着越来越多的临床证据支持神经刺激设备在治疗各种神经系统疾病的有效性，医生越来越多地向患者推荐这些疗法。此外，患者权益组织和宣传活动在向大众普及神经刺激的潜在益处方面发挥了至关重要的作用，从而提高了患者对这些疗法的接受度。患者透过神经刺激设备显着改善生活品质的成功案例，进一步增强了人们对这些疗法的正面看法。随着人们对神经调节的信任度不断提升，预计对这些设备的需求将会增加，从而推动市场扩张。此外，医疗保健机构、研究人员和设备製造商之间为提高认知度并确保合理使用而进行的合作，将有助于神经刺激设备市场的持续成长。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球神经刺激设备市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：按刺激类型

  • 内部刺激
  • 外部刺激

第七章：市场区隔：依设备类型

  • SCS（脊髓刺激）设备
  • DBS（深部脑部刺激）设备
  • SNS（荐神经刺激）设备
  • 迷走神经刺激 (VNS) 设备
  • GES（胃电刺激）设备
  • 经皮电神经刺激装置
  • 经颅磁刺激装置
  • 其他的

第 8 章：市场区隔：按应用

  • 疼痛管理
  • 癫痫
  • 特发性震颤
  • 尿失禁和大便失禁
  • 沮丧
  • 肌张力失调
  • 帕金森氏症
  • 其他的

第九章：市场区隔：依最终用户

  • 復健中心
  • 医院
  • 医疗诊所
  • 其他的

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

  • 概述
  • 入站物流
  • 营运
  • 出站物流
  • 行销和销售
  • 售后服务

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格指标

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Biocontrol Medical
    • Boston Scientific Corporation
    • Cyberonics Inc.
    • Medtronic Inc.
    • Neuronetics Inc.
    • Neuropace Inc.
    • Neurosigma Inc.
    • Nevro Corporation
    • ST. Jude Medical Inc.
    • Synapse Biomedical Inc.
Product Code: SR112025A1892

The global neurostimulation devices market size reached USD 9.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 22.0 Billion by 2033, exhibiting a growth rate (CAGR) of 9.21% during 2025-2033. The growing aging population coupled with the rising healthcare expenditure, development of non-invasive or minimally invasive neurostimulation technologies, and improved reimbursement policies by government and private health insurers are some of the major factors propelling the market.

Neurostimulation devices are advanced medical technologies designed to modulate and influence neural activity within the human body. These devices work by delivering electrical or magnetic impulses to specific regions of the nervous system, aiming to alleviate various neurological conditions and chronic disorders. They offer a promising non-invasive or minimally invasive therapeutic approach, enhancing the quality of life for patients and potentially opening up new avenues for treating various neurological disorders. The two primary types of neurostimulation devices are deep brain stimulation and spinal cord stimulation. DBS involves implanting electrodes into targeted brain areas to regulate abnormal neural signals and treat conditions such as Parkinson's disease, essential tremor, and dystonia.

The growing aging population is driving the global market. As the elderly population grows, the demand for neurostimulation devices to manage these conditions is likely to rise. Moreover, the development of non-invasive or minimally invasive neurostimulation technologies has expanded the potential patient pool, as these options often offer reduced risks and quicker recovery times compared to traditional surgical procedures. Besides, improved reimbursement policies by government and private health insurers in some regions have made neurostimulation treatments more accessible to patients, encouraging market growth. Also, ongoing research and clinical trials have provided additional evidence for the safety and efficacy of neurostimulation devices. Positive results from these studies have increased confidence in the technology among medical professionals and patients. Furthermore, the rising healthcare expenditure is supporting the growth of market solutions as neurostimulation devices offer a cost-effective approach to managing chronic conditions, which has driven their adoption.

Neurostimulation Devices Market Trends/Drivers:

Increasing Prevalence of Neurological Disorders

Neurological conditions such as Parkinson's disease, epilepsy, chronic pain, and depression affect millions of people worldwide, leading to significant healthcare burdens. Neurostimulation devices offer a promising solution for patients who are refractory to conventional treatments or experience severe side effects. Deep brain stimulation (DBS) has demonstrated remarkable efficacy in managing movement disorders, such as Parkinson's disease, thereby augmenting the demand for these devices. Additionally, the escalating incidence of chronic pain, particularly due to aging populations and sedentary lifestyles, fuels the need for spinal cord stimulation (SCS) devices to provide pain relief without relying heavily on medications. As governments and healthcare organizations prioritize improved patient outcomes and seek innovative solutions, the demand for neurostimulation devices is expected to grow steadily.

Continual Advancements in Neurostimulation Technologies

Continuous research and development efforts have led to the creation of more sophisticated and targeted neurostimulation devices. Innovations include smaller and more precise electrodes, improved battery life, and the integration of closed-loop systems that can automatically adjust stimulation parameters based on real-time patient needs. These advancements translate to enhanced treatment outcomes, reduced side effects, and increased patient comfort. Moreover, the development of minimally invasive procedures for implanting neurostimulation devices has expanded their applicability to a broader patient population, making the treatments more accessible and appealing to both patients and healthcare providers. As technology continues to evolve, neurostimulation devices will likely become even more efficient and adaptable, further impelling their adoption and market penetration.

Growing Awareness and Acceptance of Neuromodulation Therapies

As more clinical evidence supports the effectiveness of neurostimulation devices in treating various neurological disorders, medical practitioners increasingly recommend these therapies to their patients. Additionally, patient advocacy groups and awareness campaigns have played a crucial role in educating individuals about the potential benefits of neurostimulation, leading to greater patient acceptance of these treatments. The success stories of patients who have experienced significant improvements in their quality of life through neurostimulation devices have further contributed to the positive perception of these therapies. As trust in neuromodulation grows, the demand for these devices is expected to increase, fuelling the market expansion. Furthermore, collaborations between healthcare organizations, researchers, and device manufacturers to spread awareness and ensure appropriate usage will contribute to the sustained growth of the neurostimulation devices market.

Neurostimulation Devices Industry Segmentation:

Breakup by Stimulation Type:

  • Internal Stimulation
  • External Stimulation

Internal stimulation devices form a significant segment within the neurostimulation market, characterized by their implantable nature. These devices are surgically placed within the body to deliver targeted electrical or magnetic stimulation directly to specific neural structures. The demand for internal stimulation devices is driven by their efficacy in managing complex neurological disorders that do not respond adequately to medications or other treatments. The ability to precisely target neural circuits while providing reversible and adjustable stimulation parameters enhances treatment outcomes, leading to improved patient quality of life.

On the other hand, external stimulation devices represent another substantial segment in the neurostimulation market, characterized by their non-invasive or minimally invasive nature. These devices are applied externally to the body's surface, delivering stimulation without the need for surgical implantation.

Breakup by Device Type:

  • SCS (Spinal Cord Stimulation) Devices
  • DBS (Deep Brain Stimulation) Devices
  • SNS (Sacral Nerve Stimulation) Devices
  • VNS (Vagus Nerve Stimulation) Devices
  • GES (Gastric Electrical Stimulation) Devices
  • Transcutaneous Electrical Nerve Stimulation Devices
  • Transcranial Magnetic Stimulation Devices
  • Others

SCS (spinal cord stimulation) dominates the market

SCS involves the implantation of electrodes along the spinal cord, where electrical impulses are delivered to modulate pain signals and provide relief for chronic pain conditions. The minimally invasive nature of the procedure offers numerous benefits, including shorter recovery times and reduced risks compared to invasive surgeries. Additionally, the customizable nature of SCS allows for individualized programming to target specific pain areas, tailoring treatment to meet each patient's unique needs. Moreover, continual advancements in SCS technology have led to more sophisticated devices with improved battery life, smaller implants, and enhanced programming capabilities, providing greater patient comfort and long-term sustainability. The focus on patient-centered care and shared decision-making has led to an increased emphasis on personalized pain management plans. Spinal cord stimulation, with its individualized programming capabilities, aligns well with this patient-centric approach, fueling its adoption in pain management strategies.

Breakup by Application:

  • Pain Management
  • Epilepsy
  • Essential Tremors
  • Urinary and Fecal Incontinence
  • Depression
  • Dystonia
  • Parkinson's Disease
  • Others

Pain management dominates the market

Neurostimulation devices designed for pain management offer a promising alternative, particularly spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS). These technologies work by delivering controlled electrical impulses to target nerves, modulating pain signals, and thereby reducing the perception of pain. Pain management through neurostimulation has demonstrated remarkable efficacy in various chronic pain conditions, including neuropathic pain, failed back surgery syndrome (FBSS), and complex regional pain syndrome (CRPS). Additionally, the advancements in neurostimulation technology have led to more personalized and precise pain management solutions, allowing for tailored treatment strategies based on individual patient needs.

Breakup by End-User:

  • Rehabilitation Centers
  • Hospitals
  • Medical Clinics
  • Others

Hospitals dominates the market

Hospitals play a central role in the diagnosis, treatment, and management of various neurological and chronic disorders, which often require neurostimulation therapies as part of the treatment plan. Hospitals have access to multidisciplinary teams of medical professionals, including neurologists, neurosurgeons, pain specialists, and anesthesiologists, who collaborate to provide comprehensive care to patients requiring neurostimulation therapies. Additionally, they are equipped with state-of-the-art operating rooms and facilities that meet stringent regulatory standards, ensuring safe and effective implantation procedures. Furthermore, neurostimulation devices often require careful programming and adjustments to optimize treatment outcomes, and hospitals have the resources to support these ongoing patient management needs.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest neurostimulation devices market share.

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others), Latin America (Brazil, Mexico, and Others), and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America has a well-established healthcare infrastructure and is at the forefront of medical research and technological advancements. The presence of leading healthcare facilities, specialized neurology centers, and renowned research institutions fosters innovation and the adoption of cutting-edge neurostimulation technologies. Moreover, the region has a high prevalence of neurological disorders and chronic pain conditions, leading to a substantial demand for neurostimulation devices for effective management and treatment. The region's aging population, coupled with a growing awareness of neurostimulation therapies among patients and healthcare providers, further fuels market growth. Additionally, favorable reimbursement policies and regulatory frameworks in North America support the widespread adoption of neurostimulation devices.

Competitive Landscape:

Neurostimulation device manufacturers are heavily investing in research and development to enhance their existing products and develop new, innovative technologies. This involves conducting clinical trials, exploring new applications for neurostimulation, and improving the safety and efficacy of their devices. Moreover, companies are introducing new neurostimulation devices or release upgraded versions of existing ones. These launches aim to provide patients and healthcare professionals with state-of-the-art solutions that offer better outcomes and user experiences. Furthermore, companies actively seek to expand their market presence, both geographically and in terms of applications. They may pursue regulatory approvals in different regions, explore new therapeutic areas for neurostimulation, or target specific patient populations with unmet needs. Also, collaboration with other companies, research institutions, and healthcare organizations is common in the neurostimulation devices market.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Biocontrol Medical
  • Boston Scientific Corporation
  • Cyberonics Inc.
  • Medtronic Inc.
  • Neuronetics Inc.
  • Neuropace Inc.
  • Neurosigma Inc.
  • Nevro Corporation
  • ST. Jude Medical Inc.
  • Synapse Biomedical Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global neurostimulation devices market in 2024?
  • 2.What is the expected growth rate of the global neurostimulation devices market during 2025-2033?
  • 3.What are the key factors driving the global neurostimulation devices market?
  • 4.What has been the impact of COVID-19 on the global neurostimulation devices market?
  • 5.What is the breakup of the global neurostimulation devices market based on the device type?
  • 6.What is the breakup of the global neurostimulation devices market based on the application?
  • 7.What is the breakup of the global neurostimulation devices market based on the end-user?
  • 8.What are the key regions in the global neurostimulation devices market?
  • 9.Who are the key players/companies in the global neurostimulation devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Neurostimulation Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Stimulation Type

  • 6.1 Internal Stimulation
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 External Stimulation
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Device Type

  • 7.1 SCS (Spinal Cord Stimulation) Devices
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 DBS (Deep Brain Stimulation) Devices
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 SNS (Sacral Nerve Stimulation) Devices
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 VNS (Vagus Nerve Stimulation) Devices
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 GES (Gastric Electrical Stimulation) Devices
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Transcutaneous Electrical Nerve Stimulation Devices
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Transcranial Magnetic Stimulation Devices
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Others
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Pain Management
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Epilepsy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Essential Tremors
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Urinary and Fecal Incontinence
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Depression
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Dystonia
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Parkinson's Disease
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast
  • 8.8 Others
    • 8.8.1 Market Trends
    • 8.8.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Rehabilitation Centers
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Medical Clinics
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Germany
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 France
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 United Kingdom
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 Italy
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Spain
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Russia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 China
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 Japan
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 India
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 South Korea
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Australia
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Indonesia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

  • 12.1 Overview
  • 12.2 Inbound Logistics
  • 12.3 Operations
  • 12.4 Outbound Logistics
  • 12.5 Marketing and Sales
  • 12.6 Post Sales Services

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Indicators

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Biocontrol Medical
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Boston Scientific Corporation
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Cyberonics Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Medtronic Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Neuronetics Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Neuropace Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Neurosigma Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Nevro Corporation
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 ST. Jude Medical Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Synapse Biomedical Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Neurostimulation Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Neurostimulation Devices Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Neurostimulation Devices Market: Breakup by Stimulation Type (in %), 2024
  • Figure 4: Global: Neurostimulation Devices Market: Breakup by Device Type (in %), 2024
  • Figure 5: Global: Neurostimulation Devices Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Neurostimulation Devices Market: Breakup by End-User (in %), 2024
  • Figure 7: Global: Neurostimulation Devices Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Neurostimulation Devices Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 9: Global: Neurostimulation Devices (Internal Stimulation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Neurostimulation Devices (Internal Stimulation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Neurostimulation Devices (External Stimulation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Neurostimulation Devices (External Stimulation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Neurostimulation Devices (Spinal Cord Stimulation Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Neurostimulation Devices (Spinal Cord Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Neurostimulation Devices (Deep Brain Stimulation Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Neurostimulation Devices (Deep Brain Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Neurostimulation Devices (Sacral Nerve Stimulation Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Neurostimulation Devices (Sacral Nerve Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Neurostimulation Devices (Vagus Nerve Stimulation Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Neurostimulation Devices (Vagus Nerve Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Neurostimulation Devices (Gastric Electrical Stimulation Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Neurostimulation Devices (Gastric Electrical Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Neurostimulation Devices (Transcutaneous Electrical Nerve Stimulation Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Neurostimulation Devices (Transcutaneous Electrical Nerve Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Neurostimulation Devices (Transcranial Magnetic Stimulation Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Neurostimulation Devices (Transcranial Magnetic Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Neurostimulation Devices (Other Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Neurostimulation Devices (Other Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Neurostimulation Devices (Pain Management) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Neurostimulation Devices (Pain Management) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Neurostimulation Devices (Epilepsy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Neurostimulation Devices (Epilepsy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Neurostimulation Devices (Essential Tremors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Neurostimulation Devices (Essential Tremors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Neurostimulation Devices (Urinary and Fecal Incontinence) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Neurostimulation Devices (Urinary and Fecal Incontinence) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Neurostimulation Devices (Depression) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Neurostimulation Devices (Depression) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Neurostimulation Devices (Dystonia) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Neurostimulation Devices (Dystonia) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Global: Neurostimulation Devices (Parkinson's Disease) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Global: Neurostimulation Devices (Parkinson's Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Global: Neurostimulation Devices (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Global: Neurostimulation Devices (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Global: Neurostimulation Devices (Rehabilitation Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Global: Neurostimulation Devices (Rehabilitation Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Global: Neurostimulation Devices (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Global: Neurostimulation Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Global: Neurostimulation Devices (Medical Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Global: Neurostimulation Devices (Medical Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Global: Neurostimulation Devices (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Global: Neurostimulation Devices (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: North America: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: North America: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: United States: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: United States: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Canada: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Canada: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Europe: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Europe: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Germany: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Germany: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: France: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: France: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: United Kingdom: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: United Kingdom: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Italy: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Italy: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Spain: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Spain: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Russia: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Russia: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Others: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Others: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Asia Pacific: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Asia Pacific: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: China: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: China: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Japan: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Japan: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: India: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: India: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: South Korea: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: South Korea: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Australia: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Australia: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Indonesia: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Indonesia: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Others: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 90: Others: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 91: Latin America: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 92: Latin America: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 93: Brazil: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 94: Brazil: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 95: Mexico: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 96: Mexico: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 97: Others: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 98: Others: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 99: Middle East and Africa: Neurostimulation Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 100: Middle East and Africa: Neurostimulation Devices Market: Breakup by Country (in %), 2024
  • Figure 101: Middle East and Africa: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 102: Global: Neurostimulation Devices Industry: SWOT Analysis
  • Figure 103: Global: Neurostimulation Devices Industry: Value Chain Analysis
  • Figure 104: Global: Neurostimulation Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Neurostimulation Devices Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Neurostimulation Devices Market Forecast: Breakup by Stimulation Type (in Million USD), 2025-2033
  • Table 3: Global: Neurostimulation Devices Market Forecast: Breakup by Device Type (in Million USD), 2025-2033
  • Table 4: Global: Neurostimulation Devices Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Neurostimulation Devices Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 6: Global: Neurostimulation Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Neurostimulation Devices Market: Competitive Structure
  • Table 8: Global: Neurostimulation Devices Market: Key Players